Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Nutrigenomics Market, by Product
1.4.2 North America Nutrigenomics Market, by End User
1.4.3 North America Nutrigenomics Market, by Application
1.4.4 North America Nutrigenomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Nutrigenomics Market by Product
4.1 North America Reagents & Kits Market by Country
4.2 North America Services Market by Country
Chapter 5. North America Nutrigenomics Market by End User
5.1 North America Hospitals & Clinics Market by Country
5.2 North America Online Platforms Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Nutrigenomics Market by Application
6.1 North America Obesity Market by Country
6.2 North America Diabetes Market by Country
6.3 North America Cardiovascular Diseases Market by Country
6.4 North America Cancer Research Market by Country
Chapter 7. North America Nutrigenomics Market by Country
7.1 US Nutrigenomics Market
7.1.1 US Nutrigenomics Market by Product
7.1.2 US Nutrigenomics Market by End User
7.1.3 US Nutrigenomics Market by Application
7.2 Canada Nutrigenomics Market
7.2.1 Canada Nutrigenomics Market by Product
7.2.2 Canada Nutrigenomics Market by End User
7.2.3 Canada Nutrigenomics Market by Application
7.3 Mexico Nutrigenomics Market
7.3.1 Mexico Nutrigenomics Market by Product
7.3.2 Mexico Nutrigenomics Market by End User
7.3.3 Mexico Nutrigenomics Market by Application
7.4 Rest of North America Nutrigenomics Market
7.4.1 Rest of North America Nutrigenomics Market by Product
7.4.2 Rest of North America Nutrigenomics Market by End User
7.4.3 Rest of North America Nutrigenomics Market by Application
Chapter 8. Company Profiles
8.1 Genova Diagnostics
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Metagenics, Inc.
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Acquisition and Mergers:
8.2.3 SWOT Analysis
8.3 Nutrigenomix Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.2.2 Product Launches and Product Expansions:
8.3.3 SWOT Analysis
8.4 Unilever PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 The Gene Box
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 Cura Integrative Medicine
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Fagron Genomics S.L.U. (GX Sciences Inc.)
8.7.1 Company Overview
8.7.2 SWOT Analysis
8.8 Xcode Life Sciences Private Limited
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Product Launches and Product Expansions:
8.8.3 SWOT Analysis
8.9 DNA Life
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. BASF SE
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis
Unique Offerings 